AstraZeneca PLC ADR (AZN)

NASDAQ


Symbol		Exchange		Currency
AZN	·	NASDAQ	·	USD	Real-time
AZNl	·	BATS Europe	·	GBP	Delayed
AZNs	·	BATS Europe	·	SEK	Delayed
AZNCF	·	OTC Markets	·	USD	Delayed
AZN	·	London	·	GBP	Real-time
3SAZ	·	London	·	GBP	Real-time
3LAZ	·	London	·	GBP	Real-time
AZNN	·	Mexico	·	MXN	Delayed
AZNN	·	BIVA	·	MXN	Delayed
AZN	·	Stockholm	·	SEK	Real-time
AZNPy	·	TradeGate	·	EUR	Delayed
AZNPy	·	Frankfurt	·	EUR	Delayed
AZN	·	Xetra	·	EUR	Delayed
AZN	·	TradeGate	·	EUR	Delayed
AZN	·	Frankfurt	·	EUR	Delayed
AZNm	·	Buenos Aires	·	ARS	Delayed
A1ZN34	·	B3	·	BRL	Delayed
AZNA	·	Vienna	·	EUR	Real-time

Currency in USD

66.23

-1.49(-2.20%)

Closed·14/05

Pre Market

67.93+1.70(+2.57%)

·08:40:07

Fair Value

Unlock Value

Day's Range

66.16

68.22

52 wk Range

61.24

87.68

AZN Income Statement

Explore the detailed AstraZeneca PLC ADR income statement, offering a comprehensive view of the company’s financial performance. Review essential metrics such as revenue, gross profit, operating income, and net income over selected periods. This page provides a clear breakdown of profitability and operational efficiency, helping you evaluate AstraZeneca PLC ADR's growth trends and overall financial health.

Advanced Income Statement

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

26,617

37,417

44,351

45,811

54,073

Total Revenues Growth

aa.aa

+9.16%

+40.58%

+18.53%

+3.29%

+18.03%

Cost Of Revenues

aa.aa

5,246

12,005

8,641

8,040

9,638

Gross Profit

aa.aa

21,371

25,412

35,710

37,771

44,435

Gross Profit Growth

aa.aa

+9.39%

+18.91%

+40.52%

+5.77%

+17.64%

Gross Profit Margin %

aa.aa

80.29%

67.92%

80.52%

82.45%

82.18%

Other Operating Expenses, Total

aa.aa

17,001

22,515

26,898

28,123

31,506

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+3.24%	+32.43%	+19.47%	+4.55%	+12.03%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5,901	8,049	9,669	10,373	12,243
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	11,586	14,673	17,460	18,025	19,453
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-486	-207	-231	-275	-190

Operating Income

aa.aa

4,370

2,897

8,812

9,648

12,929

Operating Income Growth

aa.aa

+42.44%

-33.71%

+204.18%

+9.49%

+34.01%

EBIT Margin %

aa.aa

16.42%

7.74%

19.87%

21.06%

23.91%

Net Interest Expenses

aa.aa

-661

-733

-836

-918

-1,058

Net Interest Expenses Growth

aa.aa

-4.09%

-10.89%

-14.05%

-9.81%

-15.25%

Interest Expense, Total

aa.aa

-738

-776

-917

-1,219

-1,403

Interest And Investment Income

aa.aa

301

345

Other Non Operating Expenses, Total

aa.aa

-548

-562

-391

-338

-204

EBT, Excl. Unusual Items

aa.aa

3,161

1,602

7,585

8,392

11,667

Gain (Loss) On Sale Of Assets

aa.aa

1,055

509

216

292

Other Unusual Items, Total

aa.aa

-49

-1,869

-1,099

-1,181

-1,882

EBT, Incl. Unusual Items

aa.aa

3,916

-265

2,501

6,899

8,691

EBT, Incl. Unusual Items Growth

aa.aa

+152.97%

-106.77%

+1,043.77%

+175.85%

+25.97%

EBT, Incl. Unusual Items Margin

aa.aa

14.71%

-0.71%

5.64%

15.06%

16.07%

Income Tax Expense

aa.aa

772

-380

-792

938

1,650

Net Income to Company

aa.aa

3,144

115

3,293

5,961

7,041

Minority Interest

aa.aa

-3

-5

-6

Net Income

aa.aa

3,196

112

3,288

5,955

7,035

Net Income Growth

aa.aa

+139.4%

-96.5%

+2,835.71%

+81.11%

+18.14%

Net Income Margin %

aa.aa

12.01%

0.3%

7.41%

13%

13.01%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

3,196

112

3,288

5,955

7,035

Basic EPS - Continuing Operations

aa.aa

2.44

0.08

2.12

3.84

4.54

Basic EPS - Continuing Operations Growth

aa.aa

+137.39%

-96.76%

+2,589.19%

+81%

+18.06%

Diluted EPS - Continuing Operations

aa.aa

2.44

0.08

2.11

3.81

4.5

Diluted EPS - Continuing Operations Growth

aa.aa

+137.39%

-96.76%

+2,571.43%

+80.57%

+18.11%

Basic Weighted Average Shares Outstanding

aa.aa

1,312

1,418

1,548

1,549

1,550

Diluted Weighted Average Shares Outstanding

aa.aa

1,313

1,427

1,560

1,562

1,563

Dividend Per Share

aa.aa

2.8

2.87

2.9

3.1

Dividend Per Share Growth

aa.aa

+2.5%

+1.05%

+6.9%

EBITDA

aa.aa

6,990

6,701

13,744

14,224

17,567

EBITDA Growth

aa.aa

+25.38%

-4.13%

+105.1%

+3.49%

+23.5%

EBITDA Margin %

aa.aa

26.26%

17.91%

30.99%

31.05%

32.49%

EBIT

aa.aa

4,370

2,897

8,812

9,648

12,929

* In Millions of USD (except for per share items)

US 30

41,904.50

-146.6

-0.35%

US 500

5,870.90

-21.7

-0.37%

Dow Jones

42,051.06

-89.37

-0.21%

S&P 500

5,892.58

+6.03

+0.10%

Nasdaq

19,146.81

+136.72

+0.72%

S&P 500 VIX

18.80

+0.18

+0.97%

Dollar Index

100.56

-0.313

-0.31%

Market Movers

Name	Last	Chg. %	Vol.
NVDA	135.34	+4.16%	281.18M
TSLA	347.68	+4.07%	137.00M
PLTR	130.18	+1.62%	96.61M
AMD	117.72	+4.68%	86.74M
AAPL	212.33	-0.28%	49.33M
UNH	308.01	-1.08%	40.03M
MSFT	452.94	+0.85%	19.90M

Trending Stocks

Name	Last	Chg. %	Vol.
NVDA	135.34	+4.16%	281.18M
TSLA	347.68	+4.07%	137.00M
SMCI	45.00	+15.71%	169.22M
UNH	308.01	-1.08%	40.03M
AMD	117.72	+4.68%	86.74M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaa	22.02	+52.89%	33.67
Aaaaaaa	34.56	+41.19%	48.80
Aaaa Aaaaaaaaaaaaaaa	75.29	+36.86%	103.04
Aa Aaaaa	108.48	+28.08%	138.94
Aaaaaaaaaaaaaaaa	141.67	+26.00%	178.50
Aaaaaaaa	27.17	+24.54%	33.84
Aaaaaaaa Aaaaaaa A	76.28	+24.03%	94.61

Name	Last	Upside	Fair Value
A Aaaa	22.02	+52.89%	33.67
Aaaaaaa	34.56	+41.19%	48.80
Aaaa Aaaaaaaaaaaaaaa	75.29	+36.86%	103.04
Aa Aaaaa	108.48	+28.08%	138.94
Aaaaaaaaaaaaaaaa	141.67	+26.00%	178.50
Aaaaaaaa	27.17	+24.54%	33.84
Aaaaaaaa Aaaaaaa A	76.28	+24.03%	94.61

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Name	Last	Chg. %	Vol.
TECH	47.86	-7.27%	2.85M
RVTY	91.02	-5.88%	1.74M
IQV	141.82	-5.88%	2.74M
MRNA	24.02	-5.77%	12.81M
ABBV	177.44	-5.62%	12.21M
TMO	406.05	-5.34%	3.20M
BMY	44.12	-5.30%	21.97M

Popular Searches

Please try another search

AstraZeneca PLC ADR (AZN)

AZN Income Statement

Trending Stocks